[Thromboelastographic Studies on the Blood Clot Structure in the Sanarelli-Shwartzman Phenomenon]

Overview

Journal Klin Wochenschr

Specialty General Medicine

Date 1963 Mar 1

PMID 13936557

Citations 1

Authors

G Muller-Berghaus

H J KRECKE

H G Lasch

Affiliations

Soon will be listed here.

Citing Articles

[THE PHYSIOLOGIC INHIBITORS OF BLOOD COAGULATION IN PATHOLOGICALLY INCREASED COAGULABILITY IN VIVO. II. SERUM INFUSION INTO THE BLOOD STREAM].

Schimpf K, CIBELIUS A, MARDINI R Klin Wochenschr. 1964; 42:637-40.

PMID: 14248608 DOI: 10.1007/BF01480098.

References

Fletcher A, ALKJAERSIG N, Sherry S . Pathogenesis of the coagulation defect developing during pathological plasma proteolytic ("fibrinolytic") states. I. The significance of fibrinogen proteolysis and circulating fibrinogen breakdown products. J Clin Invest. 1962; 41:896-916. PMC: 290991. DOI: 10.1172/JCI104546. View

KLEINMAIER H, GOERGEN K, Lasch H, KRECKE H, Bohle A . [Studies on the problem of blood coagulation disorder in the Sanarelli-Shwartzman phenomena (so-called generalized Shwartzman phenomenon) of the rabbit]. Z Gesamte Exp Med. 1959; 132:275-94. View

CHRYSSANTHOU C, ANTOPOL W . Effect of trypsin inhibitors on Shwartzman phenomenon. Proc Soc Exp Biol Med. 1961; 108:587-91. DOI: 10.3181/00379727-108-27004. View

ALKJAERSIG N, Fletcher A, Sherry S . Pathogenesis of the coagulation defect developing during pathological plasma proteolytic ("fibrinolytic") states. II. The significance, mechanism and consequences of defective fibrin polymerization. J Clin Invest. 1962; 41:917-34. PMC: 290992. DOI: 10.1172/JCI104547. View

Gross R, Hartl W, KLOSS G, Rahn B . [Thrombolysis by infusions of highly purified streptokinase. Experience and research on the first 50 patients]. Dtsch Med Wochenschr. 1960; 85:2129-41. DOI: 10.1055/s-0028-1112707. View

JUNG E, DUCKERT F . [The effect of plasmin (fibrinolysin) on blood coagulation factors]. Schweiz Med Wochenschr. 1960; 90:1239-41. View

LUSCHER E . [Physiological significance of thrombocytes]. Schweiz Med Wochenschr. 1956; 86(14):345-51. View

Thomas L, GOOD R . Studies on the generalized Shwartzman reaction: I. General observations concerning the phenomenon. J Exp Med. 1952; 96(6):605-24. PMC: 2136175. DOI: 10.1084/jem.96.6.605. View

Brunson J, Thomas L, Gamble C . Morphologic changes in rabbits following the intravenous administration of meningococcal toxin. II. Two appropriately spaced injections; the rôle of fibrinoid in the generalized Shwartzman reaction. Am J Pathol. 1955; 31(4):655-67. PMC: 1942549. View

10.

PFAU P, Lasch H, GUENTHER O . [The Sanarelli-Shwartzman phenomenon in febrile abortions and severe shock and hemorrhagic conditions in obstetrics]. Gynaecologia. 1960; 150:17-33. View

11.

Niewiarowski S, Kowalski E, Stachurska J . Influence of fibrinogen derived antithrombin (antithrombin VI) on the blood coagulation system. Acta Biochim Pol. 1959; 6(1):43-53. View

12.

Fletcher A, ALKJAERSIG N, Sherry S . The maintenance of a sustained thrombolytic state in man. I. Induction and effects. J Clin Invest. 1959; 38(7):1096-110. PMC: 293257. DOI: 10.1172/JCI103886. View

13.

Koller F . [Fibrinolysis]. Schweiz Med Wochenschr. 1960; 90:1233-8. View

14.

Koller F, Gasser C, KRUSI G, DE MURALT G . [Postscarlatinal fulminant purpura with deficient V factor and excessive antithrombin]. Acta Haematol. 1950; 4(1):33-55. DOI: 10.1159/000203705. View

15.

LUESCHER E . [Biochemical properties and physiological significance of the blood platelets]. Schweiz Med Wochenschr. 1959; 89:1021-6. View

16.

Niewiarowski S, Kowalski E . [A new anticoagulant derived from fibrinogen]. Rev Hematol. 1958; 13(3):320-8. View

17.

McKAY D, Shapiro S . Alterations in the blood coagulation system induced by bacterial endotoxin. I. In vivo (generalized Shwartzman reaction). J Exp Med. 1958; 107(3):353-67. PMC: 2136684. DOI: 10.1084/jem.107.3.353. View

18.

Thomas L . The physiological disturbances produced by endotoxins. Annu Rev Physiol. 1954; 16:467-90. DOI: 10.1146/annurev.ph.16.030154.002343. View